Study was joint effort of the National Kidney Foundation, the U.S. Food and Drug Administration and the European Medicines Agency
New York, NY – August 28, 2019 - The American Journal of Kidney Diseases (AJKD) will publish today an article summarizing the deliberations and recommendations from a Scientific Workshop that was a joint effort of the National Kidney Foundation (NKF), the Food and...
Award-winning actress and NKF’s chief medical officer take their message directly to the American Academy of Family Physicians
Sept. 30, 2021, New York, NY — Family doctors and primary care practices need to ramp up kidney disease testing, using both a blood and...
Update from the Centers for Disease Control and Prevention still shows most with CKD don’t know they have it
New York, NY – July 17, 2019 – The number of American adults who have chronic kidney disease (CKD) is now estimated to be 37 million – that’s one out of every seven or 15 percent of the adult population – according to ...
~ Fundación Mas Comprometida Que Nunca Con Mejorar La Equidad En La Salud Renal ~
(19 de abril de 2024, New York, NY) —La Fundación Nacional del Riñón (NKF) se enorgullece en anunciar un progreso significativo en su misión de mejorar la equidad en la salud renal mediante el lanzamiento de programas y recursos esenciales para pacientes en español. Esta iniciativa refleja la...
Dozens of experts, patients and policy makers expected to attend
June 27, 2019, New York, NY – Nearly 80 nephrologists, cardiologists, diabetologists, patients and policy makers will gather in Chicago this week to share information about a human protein called sodium-glucose contransporter-2 (SGLT2), its role in diabetic kidney disease and how a new drug...
June 5, 2019
The National Kidney Foundation (NKF) applauds Senators Benjamin Cardin (D-MD) and Roy Blunt (R-MO) for introducing legislation that seeks to expand access to high-quality care for chronic kidney disease (CKD) patients. The Chronic Kidney Disease Improvement in Research and Treatment Act of 2019 (...
New online platform will provide unique and powerful infrastructure for patient engagement, research studies and public health advocacy initiatives
New York, NY — May 21, 2019 – Today the National Kidney Foundation (NKF) announced a comprehensive plan to develop the first-ever national registry for patients at all stages of CKD called the NKF Patient Network. The NKF Patient Network will create an...
Quotes for attribution to National Kidney Foundation
April 14, 2019
“Data from the CREDENCE trial published today in the New England Journal of Medicine demonstrate that INVOKANA® (Canagliflozin) can help reduce the risk of end stage renal disease (ESRD) and cardiovascular events in patients already diagnosed with Type 2 diabetes and chronic kidney disease (CKD). If this supplemental indication is approved by the Food and...
Authors studied lab results for 28 million Americans with the highest risk and found most are not getting recommended tests to detect life-threatening disease
August 5, 2021, New York, NY — New data suggest that millions of patients most at-risk for life-threatening kidney disease are unaware they have it because they are not tested according to clinical practice guidelines despite their risk. The study, by authors from the National...
National Kidney Foundation launches new tools for clinicians and public health practitioners to improve screening, recognition and management of the disease
New York, NY—January 9, 2019—Chronic Kidney Disease (CKD) is a largely invisible and growing public health problem that is widely under-recognized; and it is rising faster than all noninfectious diseases, including cardiovascular disease. Despite current guidelines which...
